| 000 | 00988 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250514015644.0 | ||
| 264 | 0 | _c20020227 | |
| 008 | 200202s 0 0 eng d | ||
| 022 | _a0920-3206 | ||
| 024 | 7 |
_a10.1023/a:1011968903148 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKitakaze, M | |
| 245 | 0 | 0 |
_aDoxorubicin, to treat cancers or to cause cardiac injury, that is the question. _h[electronic resource] |
| 260 |
_bCardiovascular drugs and therapy _c2001 |
||
| 300 |
_a199-200 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Editorial | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aDoxorubicin _xadverse effects |
| 650 | 0 | 4 |
_aHeart Diseases _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aRats |
| 773 | 0 |
_tCardiovascular drugs and therapy _gvol. 15 _gno. 3 _gp. 199-200 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1011968903148 _zAvailable from publisher's website |
| 999 |
_c11628496 _d11628496 |
||